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Dose and dose-rate dependence for bone sarcomas in radium-224 
patients 
A . M . K E L L E R E R , H . S P I E S S and D . C H M E L E V S K Y 
Institut für Med. Strahlenkunde der Universität Würzburg, 
Versbacher Straße 5, D-8700 Würzburg, F R G 
Risk estimates for ionizing radiations are largely based on epidemiological 
findings on persons exposed to relatively high doses of one or several gray. 
Extrapolations to the small doses relevant for radiation protection are, therefore, 
unavoidable, and such extrapolations require a variety of assumptions and models. 
The most widely used model is the linear-quadratic dose dependence. The common 
assumption is that the linear component is predominant at low doses and indepen-
dent of dose rate, while the quadratic component decreases as the dose rate is 
reduced. Accordingly one uses observed cumulative incidences of tumours at high 
doses and multiplies these with assumed dose-rate reduction factors ( D R E F ) before 
one applies a linear extrapolation to small doses. While there are differences in the 
assumed values of the D R E F , the basic rationale is accepted, and it is in line with a 
variety of observations for sparsely ionizing radiations. 
The Situation is more complex for densely ionizing radiations. Epidemiological 
data are available for incorporated a-emitters, but most of the studies, e.g. in 
uranium miners, thorotrast patients or dial painters, permit only rough Statements 
on the dose-effect relation and no conclusions concerning a dose-rate dependence. 
Experimental investigations with animals and cell studies, on the other hand, have 
recently provided evidence of a reversed time factor, i.e. of an increased effective-
ness of a specified absorbed dose when it is fractionated or protracted over hours or 
over longer durations. Such observations are of evident importance for risk 
estimates of small doses of densely ionizing radiations, and for the current 
discussion of a revision of the quality factor in radiation protection. We have 
therefore reanalysed the one set of epidemiological data, the observations on bone 
sarcomas produced in the German radium-224 patients, that can provide direct 
information on the dose-rate dependence for effects of densely ionizing radiations 
in man. 
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Shortly after World War II more than 800 patients were injected in a German 
clinic with large activities of radium-224, an a-emitter with 3-5 days half-life, for 
the intended treatment of bone tuberculosis and ankylosing Spondylitis. Subse-
quently more than 50 bone sarcomas have occurred among this collective of patients 
(Mays and Spiess 1984, Mays et a l 1986, Chmelevsky et a l 1986, 1988) . Spiess and 
Mays ( 1 9 7 3 ) concluded in an earlier analysis that, at equal mean absorbed doses in 
the skeleton, patients with longer exposure times had a higher incidence of bone 
sarcomas. The earlier analysis was based on approximations, and it did not account 
for the varying times at risk of the individual patients. A re-evaluation of the 
continued follow-up was therefore performed with more rigorous Statistical 
methods. 
In the first part of the study the existence of the reversed dose-rate effect is 
established in terms of a suitably constructed rank-order test. It is seen that at equal 
mean skeletal doses the bone sarcomas tend to occur more frequently in the patients 
who had received the injections over longer protraction periods of up to several 
years. The analysis shows that this conclusion is not due to the influence of the 
confounding factor age at treatment. In a second part of the analysis it is then 
inferred that the results are consistent with a linear no-threshold dose dependence 
under the condition of constant exposure time, while there is a steeper than linear 
dependence on dose when the exposure times increase proportionally to dose. A 
maximum-likelihood fit of the data is performed that indicates proportionality of 
the tumour expectation, R, to mean skeletal dose, D (in gray), with an added factor 
that contains the treatment time, T (in months): 
# = 0-0055 X Z ) X ( 1 + 0 - 1 8 T ) 
A n interesting implication of this relationship is that the reversed time factor 
appears to apply at small doses as well as at high doses. However, it must be noted 
that the observations pertain only to mean skeletal doses of 1 G y or more, and that 
the doses to the endosteal cells are about eight times higher. At such doses cells are 
traversed by several a-particles, and the reversed time factor can therefore be 
explained by the fact that the yield of transformed cells increases less than linearly 
with the number of a-particles per cell. 
A current epidemiological follow-up of patients subjected to present-day low-
dose radium-224 therapy of ankylosing Spondylitis is still incomplete, but it will 
ultimately add to the present experience. 
Commentary on discussion 
Osteosarcoma induction in 2 2 4 R a therapy patients is an important data resource 
for h i g h - L E T (a-particle)-induced Cancer in man. A substantial number of 
osteosarcomas have arisen in these patients and the data analysis presented by 
Kellerer represents a significant advance in our understanding of dose effect, 
particularly with regard to the distribution of mean skeletal dose and the effects of 
dose-protraction. These new analyses provide a more convincing demonstration of 
an enhanced yield of osteosarcoma with dose protraction than that originally 
provided by Spiess and Mays ( 1 9 7 3 ) . The mechanistic aspects of this and its 
relevance to human radiological risk remain, however, uncertain. Discussion 
centred on these problems and, in particular, on the relatively high a doses (~ 8 Gy) 
calculated for cells at the endosteal bone surfaces. A t this mean dose it was 
suggested that the fluence of a-particles per endosteal cell could allow for a 'reverse 
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time' factor to operate such that single target cell transformation was favoured when 
a-particle traversals were spread over time. The validity of this, particularly at such 
high total absorbed doses depends to a large extent on the intrinsic a-particle 
sensitivity of the osteogenic target cells to inactivation and possible differences in 
their patterns of proliferative response following acute and protracted a-irradiation. 
A conventional radiobiological view would make 8 G y of a-particles a supralethal 
dose to a single cell. Since, however, bone has a complex structure and the 
distribution of osteogenic target cells and 2 2 4 R a is likely to be inhomogeneous, 
'mean skeletal dose' may be a rather misleading parameter. Osteosarcomagenesis 
following such high a doses to bone could be explained if target cels were, in fact, 
located in marrow close to bone surface. Given these uncertainties we should 
perhaps exercise caution when evaluating the reverse time factor for 2 2 4 R a human 
osteosarcomagenesis and its relevance to the low-dose problems of radiological 
protection. 
